EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook Lyon, France, September 19, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in
EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies LYON, France , Oct. 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces that it has entered into a securities purchase
EDAP Launches Ablatherm-HIFU RPP Service At First South African Site LYON, France, Nov. 8, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces, together with their South African distributors, Intamed, the
EDAP Announces Third Quarter Results Conference Call LYON, France, Nov. 14, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer, announced it will release its third quarter 2007 financial results Monday, November
EDAP Announces First Published Long-Term Study of HIFU for Localized Prostate Cancer LYON, France, Dec. 13, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces the release of the first multi-center